IDXX IDEXX Laboratories, Inc.

Price (delayed)

$385.25

Market cap

$32.72B

P/E Ratio

75.69

Dividend/share

N/A

EPS

$5.09

Enterprise value

$33.89B

Sector: Healthcare
Industry: Diagnostics & Research
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: CAG, Water, LPD, and Other. The CAG segment develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services, which are used to manage the health status of livestock and poultry, to improve producer, and to ensure the quality and safety of milk and food. The Other operating segment combines and presents products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.

Highlights

The company's EPS rose by 13% YoY and by 2.4% QoQ
The company's net income rose by 12% YoY and by 2.1% QoQ
The company's equity has surged by 109% YoY but it fell by 39% QoQ
IDXX's price to earnings (P/E) is 51% higher than its 5-year quarterly average of 50.3 and 42% higher than its last 4 quarters average of 53.5
The quick ratio has decreased by 22% YoY and by 10% QoQ

Key stats

What are the main financial stats of IDXX
Market
Shares outstanding
84.93M
Market cap
$32.72B
Enterprise value
$33.89B
Valuations
Price to earnings (P/E)
75.69
Price to book (P/B)
305.3
Price to sales (P/S)
13.39
EV/EBIT
60.03
EV/EBITDA
51.79
EV/Sales
13.79
Earnings
Revenue
$2.46B
EBIT
$564.49M
EBITDA
$654.35M
Free cash flow
$286.22M
Per share
EPS
$5.09
Free cash flow per share
$3.35
Book value per share
$1.26
Revenue per share
$28.76
TBVPS
$18.67
Balance sheet
Total assets
$1.89B
Total liabilities
$1.78B
Debt
$1.25B
Equity
$107.67M
Working capital
-$124.89M
Liquidity
Debt to equity
11.6
Current ratio
0.85
Quick ratio
0.45
Net debt/EBITDA
1.79
Margins
EBITDA margin
26.6%
Gross margin
56.7%
Net margin
17.8%
Operating margin
23%
Efficiency
Return on assets
24.3%
Return on equity
265.2%
Return on invested capital
31.3%
Return on capital employed
54.3%
Return on sales
23%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDXX stock price

How has the Idexx Laboratories stock price performed over time

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$2.46B
Gross profit
$1.39B
Operating income
$564.03M
Net income
$436.87M
Gross margin
56.7%
Net margin
17.8%
The company's net income rose by 12% YoY and by 2.1% QoQ
IDXX's operating income is up by 10% YoY and by 2% from the previous quarter
The gross profit has increased by 10% YoY and by 2% QoQ
IDXX's revenue is up by 9% year-on-year and by 2.1% since the previous quarter

Valuation

What is Idexx Laboratories stock price valuation
P/E
75.69
P/B
305.3
P/S
13.39
EV/EBIT
60.03
EV/EBITDA
51.79
EV/Sales
13.79
IDXX's price to earnings (P/E) is 51% higher than its 5-year quarterly average of 50.3 and 42% higher than its last 4 quarters average of 53.5
The company's EPS rose by 13% YoY and by 2.4% QoQ
The price to book (P/B) is 114% more than the last 4 quarters average of 143.0
The company's equity has surged by 109% YoY but it fell by 39% QoQ
The P/S is 81% above the 5-year quarterly average of 7.4 and 41% above the last 4 quarters average of 9.5
IDXX's revenue is up by 9% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on invested capital has decreased by 10% YoY
Idexx Laboratories's return on equity has decreased by 7% QoQ
The return on assets has declined by 2% year-on-year

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 6% higher than its total liabilities
The quick ratio has decreased by 22% YoY and by 10% QoQ
IDXX's current ratio is down by 16% year-on-year and by 10% since the previous quarter
The company's equity has surged by 109% YoY but it fell by 39% QoQ
IDXX's debt to equity has soared by 95% QoQ but it is down by 46% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.